Satoshi Ohnuma

Title: Satoshi Ohnuma: Innovator in Medicinal Chemistry

Introduction

Satoshi Ohnuma is a distinguished inventor based in Nishinomiya, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative patent work. His research focuses on developing compounds that exhibit enhanced stability and efficacy for medicinal applications.

Latest Patents

Satoshi Ohnuma holds a patent for a compound titled "1, 2-dihydro-2-oxo-1, 8-naphthyridine derivative - Hydrates of N-[1-butyl-4-[3-[3-(hydroxy)propoxy]-phenyl]-1,2-dihydro-2-oxo-1,8-naphthyridin-3-yl]-N'-(2,6-diisopropyl-4-aminophenyl)urea hydrochloride." This compound is noted for its superior stability compared to amorphous forms, making it a more preferable option for use in medicaments.

Career Highlights

Satoshi Ohnuma is currently associated with Sumitomo Pharmaceuticals Company Limited, where he continues to advance his research in pharmaceutical development. His work has been instrumental in creating innovative solutions that address various medical needs.

Collaborations

Throughout his career, Satoshi has collaborated with notable colleagues, including Masami Muraoka and Hitoshi Ban. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Satoshi Ohnuma's contributions to medicinal chemistry through his patent work exemplify his commitment to innovation in the pharmaceutical industry. His research not only advances scientific knowledge but also holds the potential to improve patient care through more effective medications.